As pharmacologic options for presbyopia continue to expand, clinicians must move beyond simplistic “small pupil” treatment paradigms toward a more individualized, lifestyle-driven approach to patient care. In this program, attendees will explore the differing mechanisms of action among emerging presbyopia therapies.

Speaker: Cecelia Koetting, OD

Date: Tuesday, December 1, 2026

Time: 5:30 PM - 6:30 PM Pacific Time

Location: Virtual

Moderator: Pending

Cost: Free!

COPE ID: Pending

Category: Pending

This event is undergoing COPE approval for 1 hour CE credit.